Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection conducted in June 2025
It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
Expanding US operations to address the increased demand for API development and manufacturing
The new plant will manufacture high-quality Type I borosilicate glass tubing
The new line features advanced isolator technology to deliver enhanced sterility assurance, throughput and operational precision
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Subscribe To Our Newsletter & Stay Updated
